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Lymphocytes cross vascular boundaries via either
disrupted tight junctions (TJs) or caveolae to induce
tissue inflammation. In the CNS, Th17 lymphocytes
cross the blood-brain barrier (BBB) before Th1 cells;
yet this differential crossing is poorly understood.We
have used intravital two-photon imaging of the spinal
cord in wild-type and caveolae-deficient mice with
fluorescently labeled endothelial tight junctions to
determine how tight junction remodeling and caveo-
lae regulate CNS entry of lymphocytes during the
experimental autoimmune encephalomyelitis (EAE)
model for multiple sclerosis. We find that dynamic
tight junction remodeling occurs early in EAE but
does not depend upon caveolar transport. Moreover,
Th1, but not Th17, lymphocytes are significantly
reduced in the inflamed CNS of mice lacking caveo-
lae. Therefore, tight junction remodeling facilitates
Th17 migration across the BBB, whereas caveolae
promote Th1 entry into the CNS. Moreover, therapies
that target both tight junction degradation and cav-
eolar transcytosis may limit lymphocyte infiltration
during inflammation.
INTRODUCTION
During inflammation, immune cells cross blood vessels of multi-
ple organs to mount an appropriate immune response. Immune
cell trafficking across blood vessels is controlled by both cell
junctions and vesicles that regulate transport between or within
endothelial cells (Komarova et al., 2017). During CNS autoim-
mune diseases, leukocytes migrate across several pathways to
reach the CNS parenchyma. These include a vascular route2104 Cell Reports 21, 2104–2117, November 21, 2017 ª 2017 The A
This is an open access article under the CC BY-NC-ND license (http://through the blood-brain barrier (BBB) or blood-spinal cord bar-
rier (BSCB), the blood-cerebrospinal fluid route through an
epithelial barrier present in the choroid plexus, and the menin-
geal lymphatic route on the surface of the brain (Daneman and
Engelhardt, 2017; Louveau et al., 2017; Platt et al., 2017). The
BBB is characterized by impermeable tight junctions (TJs) and
reduced transcellular transcytosis (Lampugnani et al., 2015;
Reese and Karnovsky, 1967). Immune cells can extravasate
through either tight junctions (paracellular migration) or endothe-
lial vesicles (transcellular migration) (Engelhardt and Wolburg,
2004;Martinelli et al., 2014). Among the various immune cell sub-
types, T helper 1 (Th1) and T helper 17 (Th17) lymphocytes are
distinguished by unique effector cytokines that damage axons,
oligodendrocytes, and the neurovasculature (Rostami and Ciric,
2013; Simmons et al., 2014; Stromnes et al., 2008). Moreover,
Th17 cells enter the CNS before Th1 cells in experimental auto-
immune encephalomyelitis (EAE) (Murphy et al., 2010; Rothham-
mer et al., 2011). However, it is unknown whether they employ
similar or distinct mechanisms to cross endothelial barriers.
Claudin3, Claudin5, Claudin12, and Occludin are critical junc-
tional proteins that normally restrict paracellular movement of
small molecules across endothelial cell barriers (Nag, 2003; Nitta
et al., 2003). These proteins are disrupted in inflammatory dis-
eases, including multiple sclerosis and its animal model EAE
(Bennett et al., 2010; Kirk et al., 2003). Tight junction disruption
precedes overt lesion formation and correlates with clinical
severity of EAE (Alvarez et al., 2015; Fabis et al., 2008). More-
over, endothelial tight junction degradation promotes paracellu-
lar leukocyte migration (Reijerkerk et al., 2008; Winger et al.,
2014), whereas overexpression of Claudin1 is protective for
EAE (Pfeiffer et al., 2011). Endothelial tight junctions also prevent
serum proteins such as fibrinogen from crossing the BBB,
thereby conferring disease protection (Ryu et al., 2015). Tight
junctions are highly dynamic in vivo in both the cerebral cortex
and the intestinal epithelia, and their turnover is increased during
inflammation (Knowland et al., 2014; Marchiando et al., 2010).uthors.
creativecommons.org/licenses/by-nc-nd/4.0/).
Although barrier disruption promotes neuroinflammation by
enabling inflammatory proteins and leukocytes to access the
CNS, how dynamic remodeling of tight junctions correlates
with disease pathogenesis and its importance for immune cell
trafficking remain unclear.
A second mechanism controlling BBB permeability is endo-
cytic and transcytotic transport. In the CNS endothelium, most
endocytic vesicles are non-clathrin-coated caveolae containing
Caveolin1 (Cav1) (Kovtun et al., 2015; Nag, 2003). Both the
expression of Caveolin1 (Shin et al., 2005; Wu et al., 2016) and
the density of endocytotic vesicles in CNS endothelium increase
during acute multiple sclerosis and EAE (Brown, 1978; Claudio
and Brosnan, 1992). Endothelial caveolae may provide a migra-
tory route for myelin-specific T cells into the CNS (Raine et al.,
1990) because of clustering of adhesion molecules (Carman
and Martinelli, 2015; Millán et al., 2006). Caveolar activity also
enhances leukocyte migration across the meninges (Santizo
et al., 2002). Caveolae regulate cytokine-induced tight junction
turnover in epithelial and endothelial cells (Marchiando et al.,
2010; Stamatovic et al., 2009; Sun et al., 2009). However, how
caveolae regulate Th17 versus Th1 cell trafficking and tight junc-
tion remodeling at the BBB during EAE is poorly understood.
Here we examine how BBB components are disrupted in vivo
during EAE and which routes are used by distinct effector T cell
subtypes to enter the CNS. We use intravital two-photon micro-
scopy in transgenic (Tg) eGFP-Claudin5+/ mice (Knowland
et al., 2014) to visualize dynamic changes in tight junctions at
the BSCB during EAE.We find that tight junction remodeling pre-
cedes the onset of disease and barrier permeability. Moreover,
mice that lack caveolae have reduced EAE clinical severity and
a selective decrease in BSCB permeability to Th1 cells yet
display no changes in dynamic tight junction remodeling. These
findings suggest that during neuroinflammation, caveolae-inde-
pendent tight junction remodeling facilitates Th17 lymphocyte
transmigration across the BBB, whereas caveolae regulate the
entry of Th1 lymphocytes into the CNS.
RESULTS
Live Imaging of Tight Junction Structural Changes in
Healthy Spinal Cord Vessels
To document real-time changes in tight junction structure in the
spinal cord microvasculature during EAE, we used intravital two-
photon microscopy in transgenic eGFP-Claudin5+/ transgenic
mice that express a fusion of EGFP to Claudin5 in endothelial
cells (Knowland et al., 2014). We performed dorsal laminectomy
at lumbar level 1 (L1) to expose the spinal cord and time-lapse
imaging of endothelial tight junctions over 45-min intervals (n =
6–7 mice/group) (Figures 1A and 1B). We focused on post-capil-
lary venules because leukocyte transmigration occurs primarily
in such vessels during EAE and is associated with loss of
Claudin5 (Paul et al., 2013). In healthy mice, EGFP-positive tight
junctions aremostly linear (Figures 1E and 1F). In the dorsal white
matter, 25% of tight junctions in healthy blood vessels show pro-
trusions (bulbous extensions of 1–5 mmextending from themajor
tight junction segment axis); however, only 5% of protrusions
rapidly remodel (appear or disappear during imaging) (Figures
1C, 1E, 1F, 1M, and 1N; Movie S1). Moreover, healthy tight junc-tions exhibit few gaps (1.8%) (Figures 1D–1F and 1O) or tortuous,
irregular non-linearity (4.6%) (Figures 1C and 1P), which is remi-
niscent of junctions in cells lacking ZO-1 and ZO-3 proteins
(Umeda et al., 2006). Thus, only a small fraction (5%) of endothe-
lial tight junction segments undergo dynamic remodeling in the
healthy spinal cord.
Dynamic Remodeling of Tight Junctions Precedes
Disease Onset and Barrier Permeability during EAE
We next asked how tight junction remodeling correlates with
BBB permeability during EAE. We induced active EAE with
myelin oligodendrocyte glycoprotein peptide 35–55 (MOG35–55)
(Lutz et al., 2012) in Tg eGFP-Claudin5+/ mice and assessed
tight junction structure by two-photon microscopy at three
stages of disease: (1) before clinical signs (EAE score 0,
6–7 days post-immunization [dpi]), (2) in mice with tail paralysis
(EAE score 1, 10 days post-immunization), and (3) in mice with
hindlimb weakness or paralysis (EAE score 2–3, 13–15 days
post-immunization). All animals with EAE have significantly
more protrusions than healthy controls (i.e., 70% in all stages
of EAE versus 25% in controls; p < 0.001, one-way ANOVA
with Tukey’s multiple comparison) (Figures 1G–1M). Approxi-
mately 40%of tight junction protrusions in post-capillary venules
during EAE undergo rapid remodeling (Figures 1G–1N; Movie
S2). Similarly, tight junction segments with gaps and tortuous
segments are predominant at EAE score 1 (55.8% and 56.2%,
respectively) and EAE score 2 (56.5% and 64.6%, respectively),
but these defects are absent inmice before onset of clinical signs
(EAE score 0, 14.5% and 14.3%, respectively) (Figures 1G–1L,
1O, and 1P) (data not shown). Therefore, tight junction dynamic
remodeling precedes gap formation. Internalized tight junction
protrusions localize in vivo with the early endosome marker
EEA-1, but not clathrin (Figure S1). Similar to healthy mice, com-
plete Freund’s adjuvant (CFA) and pertussis toxin-treated con-
trol mice, which do not develop disease, exhibit only static pro-
trusions (50%), not dynamic protrusions (7.7%), in tight junction
segments, with few gaps (3.7%) or irregular segments (10%);
these frequencies are similar to those in healthy mice (Figures
1M–1P). Thus, tight junction dynamic remodeling and instability
are features of active EAE.
Caveolin1 Is Not Required for Tight Junction Structural
Changes in EAE Spinal Cord Vessels
Tight junction stability may be regulated by caveolae, a class
of membrane invaginations that require Caveolin1 (Cheng and
Nichols, 2016). Caveolae regulate endocytosis of tight junction
proteins and barrier permeability in brain endothelial cells
in vitro (Song et al., 2007; Stamatovic et al., 2009); however, it
is unknown whether caveolae perform similar functions at the
BBB in vivo. To address this, we immunized Cav1/ mice
(Razani et al., 2001) with MOG35–55 and assessed disease and
tight junction remodeling. EAE-induced Cav1/ mice showed
reduced disease severity compared to wild-type (WT) littermates
(n = 34, wild-type; n = 32, Cav1/; p < 0.01, two-way repeated-
measure ANOVA with Sidak’s multiple comparison test) (Fig-
ure 2A). The maximum score attained by Cav1/ mice was
lower than that attained by wild-type mice (p < 0.001, Mann-
Whitney comparison of medians) despite similar diseaseCell Reports 21, 2104–2117, November 21, 2017 2105
Figure 1. Dynamic Tight Junction Changes in Spinal Cord Blood Vessels during EAE Revealed by Intravital Two-Photon Microscopy of
Transgenic eGFP-Claudin5+/ Mice
(A and B) Dorsal laminectomy (A) and diagram of the imaging window (B) in the dorsal white matter of lumbar level 1 (L1) spinal cord in mice.
(C and D) Examples of EGFP-positive tight junction (TJ) protrusions (C), tortuosity (C), and gaps (D).
(E–L) Maximum intensity projections of two sequential time-lapse images of spinal cord venules in healthy (E and F, n = 6), preclinical (G andH, n = 5, EAE score 0),
mild EAE (I and J, n = 6, score 1), and severe EAE (K and L, n = 6, score 2–3) transgenic eGFP-Claudin5+/mice at 0- and45-min intervals. The 0 min timepoints
are shown in (E), (G), (I), and (K); 45 min timepoints are shown in (F), (H), (J), and (L). Yellow arrows show static tight junction protrusions, red arrows point to
dynamic tight junction protrusions that appear or disappear during the imaging period, blue arrows show tight junction gaps, and magenta open arrows point to
myeloid or lymphoid cells.
(M–P) Bar graphs show percentages of tight junction segments with protrusions (M), dynamic protrusions (N), gaps (O), and tortuosity (P). Each dot represents the
mean of multiple fields from a single mouse.
Bar graphs show mean ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA. Scale bars, 20 mm (C and E–L) and 10 mm (D). See also Figure S1.
2106 Cell Reports 21, 2104–2117, November 21, 2017
Figure 2. Caveolin1-Deficient Mice Display Attenuated EAE but No Changes in Tight Junction Remodeling
(A) Clinical EAE scores in wild-type (n = 34) andCav1/ (n = 32) littermate mice.Cav1/mice have less severe clinical scores at the indicated times (12–15 days
post-immunization; **p < 0.01, ***p < 0.001, two-way repeated-measure ANOVA). The graph excludes mice that died during the experiment (n = 0, wild-type;
n = 2, Cav1/).
(B) Scatterplot of maximum clinical scores attained by each mouse. Cav1/ mice had less severe scores (p < 0.001, Mann-Whitney comparison of medians).
(C) Bar graph of disease incidence.
(D and E) Maximum intensity projections of time-lapse imaging recordings at 0 min (D) and 45 min (E) for spinal cord venules in transgenic eGFP-Claudin5+/,
Cav1/ mice at EAE score 0 (n = 5–6). Yellow arrows show static protrusions, and red arrows point to dynamic protrusions that appear or disappear during the
imaging period. Scale bars, 20 mm.
(F–I) Bar graphs show percentages of tight junction segments with protrusions (F), dynamic protrusions (G), gaps (H), and tortuosity (I) between Tg
eGFP-Claudin5+/ and Tg eGFP-Claudin5+/, Cav1/ mice. No differences were found for tight junction structural features between the two geno-
types.
See also Figure S2.incidence (Figures 2B and 2C). The peripheral immune response
to MOGwas unchanged in Cav1/ mice compared to wild-type
mice (Figures S2A–S2K), consistent with a recent report (Wu
et al., 2016). In a subset of animals examined up to 25 days
post-immunization, the clinical trend remained the same (n = 5
per group; p < 0.001) (Figure S2L). Cav1/ mice with EAE had
slightly better myelin preservation in the thoracic spinal cord
than did wild-type mice with EAE (Figures S2M–S2O). However,
there was no difference in oligodendrocyte apoptosis (Figures
S2P–S2R), suggesting that caveolae do not influence oligoden-
drocyte death.Caveolae Are Not Required In Vivo during EAE for Tight
Junction Dynamic Remodeling and Permeability to
Small Molecules
We used intravital two-photon microscopy to compare tight
junction dynamic remodeling in vivo between transgenic eGFP-
Claudin5+/ Cav1/ and eGFP-Claudin5+/ mice at an early
stage of EAE (score 0, 7 days post-immunization), when we first
observe tight junction dynamic remodeling (Figures 1G, 1H, and
1M–1P). Transgenic eGFP-Claudin5+/ Cav1/ and eGFP-
Claudin5+/ mice had similar frequencies of static and dynamic
protrusions, gaps, or tortuosities (Figures 2D–2I). To correlateCell Reports 21, 2104–2117, November 21, 2017 2107
Figure 3. Paracellular BBB Leakage in Spinal Cord Blood Vessels
Biocytin-TMR was intravenously injected into transgenic eGFP-Claudin5+/ and eGFP-Claudin5+/, Cav1/ mice before in vivo imaging with two-photon
microscopy.
(A–D) Healthy and CFA and pertussis toxin control transgenic eGFP-Claudin5+/ mice had continuous tight junction segments (A and C), and biocytin-TMR was
confined within the lumen of spinal cord blood vessels (B and D).
(E and F) Transgenic eGFP-Claudin5+/ mice with EAE score 0 had some tight junction gaps (E, blue arrowheads) and minimal biocytin-TMR leakage outside of
blood vessels (F, yellow arrows).
(G–J) Transgenic eGFP-Claudin5+/ mice with EAE score 1 (G and H) and EAE score 2 (I and J) had multiple tight junction gaps (G and I, blue arrowheads) and
extensive extravascular biocytin-TMR in the spinal cord (H and J, yellow arrows).
(K and L) Transgenic eGFP-Claudin5+/, Cav-1/ mice with EAE score 1 had multiple tight junction gaps (blue arrowheads, K) and extravascular biocytin-
TMR (L).
(M and N) Graphs of biocytin-TMR fluorescence intensity in the lumbar (M) and thoracic (N) spinal cord normalized to fluorescence intensity in the liver ex vivo
(n = 4, CFA and pertussis toxin control; n = 7, EAE score 0; n = 6, EAE score 1; n = 8, EAE score 2–3).
Scale bars, 20 mm. See also Figure S3.tight junction structural changes with loss of BSCB function
in vivo, we injected transgenic eGFP-Claudin5+/ EAE, eGFP-
Claudin5+/ Cav1/ EAE, CFA and pertussis toxin controls,
and healthy eGFP-Claudin5+/ mice intravenously with 5-(and-
6-)tetramethylrhodamine biocytin (biocytin-TMR, 869 Da), which
crosses the BBB when tight junctions are disrupted (Dileepan
et al., 2016; Knowland et al., 2014; Lengfeld et al., 2017). We
visualized biocytin-TMR in the spinal cord by two-photon micro-
scopy and then normalized it ex vivo to liver accumulation from
the same animal (Figure 3). The tracer is retained within blood2108 Cell Reports 21, 2104–2117, November 21, 2017vessels in healthy and CFA-treated mice (Figures 3A–3D, 3M,
and 3N). Leakage from vessels is mild at EAE score 0 (Figures
3E, 3F, 3M, and 3N) and pronounced in symptomatic
mice, particularly at sites of tight junction gaps (EAE score 1–3)
(Figures 3G–3J, 3M, and 3N). However, there is no difference
in biocytin leakage across the BSCB between transgenic
eGFP-Claudin5+/Cav1/ and eGFP-Claudin5+/mice (Figures
3K–3N).
We also measured parenchymal deposition of the serum pro-
tein fibrinogen (approximately 340 kDa) by immunofluorescence.
Fibrin accumulation was minimal in CFA and pertussis toxin (Ptx)
controls and EAE score 0–1 mice (Figures S3A–S3I, S3P, and
S3Q). Micewith clinical EAE scores > 2 had significantly elevated
fibrinogen at thoracic and lumbar levels of the spinal cord
(Figures S3J–S3L, S3P, and S3Q), with regions of leukocyte infil-
tration displaying greatest leakage (Figures S3I, S3L, and S3O).
Transgenic eGFP-Claudin5+/ Cav1/ EAE mice and eGFP-
Claudin5+/ EAE mice have similar levels of fibrinogen leakage
(Figures S3M–S3Q), consistent with tracer leakage across the
BSCB. Thus, the presence of tight junction gaps correlates
closely with paracellular BSCB permeability in both transgenic
eGFP-Claudin5+/ EAE mice and eGFP-Claudin5+/ Cav1/
EAE mice.
We next measured leakage of albumin-Alexa Fluor 594, a
66 kDa protein that can undergo caveolar transcytosis (Tiruppa-
thi et al., 1997), during active MOG35–55 EAE in wild-type and
Cav1/ mice. We used confocal microscopy to assess endo-
thelial- and parenchymal-associated albumin (Knowland et al.,
2014; Lengfeld et al., 2017). Healthy and CFA and pertussis toxin
control mice exhibit minimal albumin-Alexa Fluor 594 uptake into
both lumbar and thoracic spinal cords (Figures 4A–4D, 4M, and
4N; Figures S4A and S4B), consistent with previous studies
(Al-Izki et al., 2012; Tonra et al., 2001). Both endothelial- and pa-
renchyma-associated albumin are significantly increased at EAE
score 2–3.5 (Figures 4G, 4H, 4M, and 4N). Albumin transport
across the endothelium depends on caveolar transcytosis in
some peripheral tissues and during ischemic stroke in the brain
(Knowland et al., 2014; Razani et al., 2001). As expected, the
absence of Cav1 prevents albumin leakage in spinal cords of
healthy mutant mice (Figures 4I, 4J, 4M, and 4N; Figures S4A
and S4B). However, Cav1/ mice with EAE have levels of endo-
thelium- or parenchymal-associated albumin similar to those of
their wild-type littermates using score-matched EAE mice (Fig-
ures 3K–3N). Thus, BSCB permeability to larger molecules
such as albumin increases at severe EAE through caveolae-in-
dependent routes.
Loss of Caveolin1 Selectively Reduces Th1 Cell
Infiltration into the CNS
We tested the role of caveolar transcytosis in T cell diapedesis.
In contrast with a recent study (Wu et al., 2016), we found
that Cav1/ mice with EAE have similar CD4+ T cell numbers
in both meningeal and parenchymal compartments 15 days
post-immunization compared to wild-type mice with EAE by
immunostaining (two-way Student’s t test) (Figures 5A–5G). To
understand how loss of Cav1 reduces the severity of EAE, we
examined lymphocyte subtypes in the spinal cord using flow
cytometry. We found that although the total number of infiltrating
T and B cells were similar between wild-type and Cav1/ mice
with active EAE, the ratio of Th1 to Th17 subtypes was signifi-
cantly altered (Figures 5H–5Q). Spinal cords of Cav1/ mice
had a selective decrease in interferon g (IFN-g)-producing Th1
cells and increased interleukin (IL)-17A-producing Th17 cells (Fig-
ures 5I, 5J, 5N, and 5O). No differences were found for IL-17a+
IFN-g+ double-positive cells (Figure 5P) or CD19+ B cells (Figures
5K and 5Q). To confirm these findings, we assessed transmigra-
tion of Th1- or Th17-enriched populations of T cells (Figures S5A–
S5C) across cultured primary brain endothelial cell (BEC) mono-layers isolated from either wild-type or Cav1/ mice (Figure 6).
We found that the Cav1/ endothelium showed a 93.5% reduc-
tion in transcellular transmigration and 49% reduction in paracel-
lular transmigration of Th1 lymphocytes (*p < 0.05) (Figures 6A–6E
and 6J). The caveolae inhibitor methyl-b-cyclodextrin (MbCD)
also suppressed Th1 transcellular transmigration across wild-
type brain endothelial cells (Figures S5D–S5G). Consistent with
our findings in vivo, there was no impairment in Th17 lymphocyte
migration across Cav1/ endothelium (Figures 6F–6J). Thus,
caveolae play an important role in allowing Th1 cell entry into
the CNS during neuroinflammation, whereas Th17 cells primarily
enter the CNS via disrupted tight junctions. Furthermore, caveo-
lae are not required for dynamic remodeling of tight junctions or
increased vascular permeability in EAE.
DISCUSSION
In this study, we have examined in vivo dynamic remodeling of
tight junctions at the BSCB in healthy living mice and during
the EAE model of multiple sclerosis. We find that tight junctions
in post-capillary venules of the spinal cord are mostly stable in
healthy mice (Figures 1M–1P); however, dynamic remodeling
of tight junctions and paracellular BSCB leakage increase before
onset of EAE and remain high throughout disease. Moreover,
endothelial tight junctions rapidly remodel independent of
caveolae in neuroinflammation, because tight junctions exhibit
similarly dynamic behavior in both wild-type and Cav1/ EAE
mice. Finally, we demonstrate that caveolae are essential for
transmigration of IFN-g-producing Th1 cells into the spinal
cord during EAE. We discuss the cell biological mechanisms un-
derlying BBB dysfunction in neurological diseases, mechanisms
of immune cell infiltration into the CNS through paracellular and
transcellular pathways, and relevance for EAE progression.
Multiple studies have suggested that endothelial barriers of
the brain, spinal cord, meninges, and choroid plexus are func-
tionally distinct from one another and from those of the periph-
eral vasculature. The BBB and BSCB differ in both expression
of barrier-specific proteins and their functional permeability.
Compared to brain, endothelial cells in the spinal cord have
decreased adherens junction (AJ) proteins (e.g., Cadherin-5
and a-, b-, and g-catenin) and tight junction proteins (e.g., Occlu-
din and ZO-1) and a corresponding increase in permeability to
low-molecular-weight tracers (Bartanusz et al., 2011). Our intra-
vital imaging studies reveal that tight junctions in white matter
spinal cord are 4-fold more dynamic (Figure 1) than those in
the cortex (Knowland et al., 2014). Thus, our findings extend pre-
vious observations that endothelial barriers differ in distinct CNS
regions. A higher rate of tight junction remodeling in the spinal
cord vasculature may contribute to its increased vulnerability
to EAE (Cruz-Orengo et al., 2014).
What regulates tight junction remodeling during inflammation?
Caveolae have been proposed to promote tight junction endocy-
tosis in vitro in CNS and non-CNS endothelial cells, as well as
in vivo in non-CNS endothelial cells (Chang et al., 2009; Miya-
waki-Shimizu et al., 2006; Rosengren et al., 2006; Schubert
et al., 2002; Song et al., 2007). However, we find that Cav1/
and wild-type mice exhibit similar kinetics of tight junction re-
modeling and BSCB vascular leakage to small-molecular-weightCell Reports 21, 2104–2117, November 21, 2017 2109
Figure 4. BBB Permeability to Albumin Is Increased at Peak EAE
(A–L) BBB leakage of intravenously injected albumin-Alexa Fluor 594 (red) in lumbar spinal cord sections from healthy (A and B), CFA and pertussis toxin control
(C and D), EAE score 1 (E and F) and EAE score 3 (G andH) wild-typemice, and healthy (I and J) and EAE score 1 (K and L)Cav1/mice. Single channel images for
albumin are shown in (A), (C), (E), (G), (I), and (K).The vascular marker Glut1 (green) labels endothelial cells, and DAPI (blue) shows nuclei. Merged psuedocolored
images are shown in (B), (D), (F), (H), (J), and (L). Yellow arrows indicate perivascular albumin.
(M and N) Bar graphs of the fraction of endothelium-associated (M) or parenchyma-associated (N) albumin that traversed the BSCB. Each dot represents the
mean of multiple fields from a single animal (n = 5–6, healthy; n = 7, CFA and pertussis toxin control; n = 6, EAE score 0; n = 6, EAE score 1–1.5; n = 13–16, EAE
score 2–3; n = 3, healthy Cav1/; n = 7, EAE score 1–1.5 Cav1/).
Bar graphs show mean ± SEM, *p < 0.05, one-way ANOVA. Scale bars, 20 mm. See also Figure S4.
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Figure 5. Cav1-Deficient Mice Have Reduced IFN-g-Producing CD4+ T Cells in the CNS
(A–F) Immunofluorescence for CD4, laminin, andDAPI in the ventral funiculus (A, B, D, and E) and lateral funiculus (C and F) of wild-type (A, CD4 [red]; B, CD4 [red],
laminin [green], DAPI [blue] merged pseudocolored image) and Cav1/ (D, CD4 [red]; E, Cd4 [red], laminin [green], DAPI [blue] merged pseudocolored image)
EAE thoracic spinal cords 15 days post-immunization. White arrows point to T cells that have crossed the basal lamina (white dotted line in A and D), whereas
yellow arrowheads point to T cells that are located in meningeal or vascular spaces. Scale bars, 200 mm (A, B, D, and E) and 10 mm (C and F).
(G) Bar graphs of CD4+ T cell numbers in parenchymal or meningeal compartments of thoracic spinal cords in wild-type and Cav1/ EAE mice 15 days post-
immunization. There is no significant difference between genotypes (n = 9, wild-type; n = 9, Cav1/; unpaired two-way Student’s t test).
(H–K) Fluorescence-activated cell sorting (FACS) plots for CD8+ and CD4+ T cells (H), IFN-g+ CD4+ T cells (I), IL-17a+ CD4+ T cells (J), and CD19+ B cells (K)
isolated from spinal cords of wild-type (n = 8) or Cav1/ (n = 8) mice 15 days post-immunization.
(L and M) Scatterplots of leukocytes gated on viable dye exclusion and high CD45 expression. There were no differences in percentages of infiltrating CD4+
CD45hi (L) or CD8+ CD45hi (M) between the two genotypes.
(N and O) Scatterplots of the fraction of IFN-g-producing CD4+ Th1 cells (N) and IL-17-producing CD4+ Th17 cells (O) in wild-type and Cav1/ EAE mice.
Significantly fewer IFN-g-producing CD4+ Th1 cells (N) and significantly more IL-17-producing CD4+ Th17 cells (O) were observed in spinal cords of Cav1/
compared to wild-type mice (n = 8, wild-type; n = 8, Cav1/; *p < 0.05, **p < 0.01, Student’s t test).
(P) Scatterplot of the fraction of IL-17+ IFN-g+ CD4+ T cells in both genotypes. There was no significant difference in the proportion of IL-17+ IFN-g+ CD4+ T cells.
(Q) Scatterplot of the fraction of CD19+ B cells in both genotypes. There was no difference in the fraction of infiltrating CD19+ B cells.tracers (e.g., biocytin-TMR) during EAE. These results extend
our prior study that tight junction remodeling is independent of
caveolae during barrier breakdown following transient middle
cerebral artery occlusion (t-MCAO), a mouse model for ischemic
stroke (Knowland et al., 2014). Our data are consistent with cav-eolae- and clathrin-independent tight junction remodeling or
degradation in the CNS endothelium during EAE. A potential
mechanism for tight junction degradation could be enhanced
endocytotic or macropinocytic remodeling or degradation in
response to inflammatory cytokines such as IFN-g (BruewerCell Reports 21, 2104–2117, November 21, 2017 2111
Figure 6. Endothelial Caveolin1 Promotes Th1, but Not Th17, Lymphocyte Transcellular Transmigration
(A) Schematic diagram of T cell transmigration states in the in vitro assay. Wild-type Th1 orRorc(gt)GFP/+ GFP+ Th17 cells were applied to monolayers of wild-type
or Cav1/ primary brain endothelial cells. Based on their positions relative to endothelial ZO-1 in confocal image stacks, T cells were scored as either loosely
adherent (non-transmigrating) or transmigrating via transcellular or paracellular routes.
(B–E) Apical and basal confocal images and orthogonal views of Th1 in vitro transmigration assay immunostained for ZO-1 (red), CD45 (green), and DAPI (blue).
Loosely adherent Th1 cells are indicated with white arrows and transmigrating Th1 cells are indicated with yellow arrowheads on wild-type brain endothelial cells
(apical slice, B; basal slice, C) or Cav1/ brain endothelial cells (apical slice, D; basal slice, E).
(legend continued on next page)
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et al., 2005). Thus, regulatorymechanisms underlying endothelial
barrier integrity and dysfunction in CNSdiseases differ from those
proposed for epithelial barriers of the intestine and endothelial
cells in the lung (G€unzel andYu, 2013). The prevalenceof dynamic
protrusions at preclinical EAE (Figures 1G, 1H, and 1N) is consis-
tent with the proposed role for neutrophils in promoting early BBB
breakdown by secretion of proteolytic enzymes (Aubé et al.,
2014; Carlson et al., 2008). The lateral border recycling compart-
ment can serve as the organelle in which rapid remodeling of tight
junction proteins occurs in brain endothelial cells in vitro as they
encounter transmigrating monocytes (Winger et al., 2014). These
organelles contain both adherens- and tight junction-associated
proteins and may correspond to the tight junction protrusions
observed by two-photon imaging in gut epithelial cells (March-
iando et al., 2010), brain endothelial cells in the ischemic brain
(Knowland et al., 2014) and spinal cord during inflammation (Fig-
ure 1). We find that CFA and pertussis primes the BSCB for re-
modeling by enhancing the number of tight junction protrusions
but is insufficient to induce tight junction dynamic remodeling
(Figure 1) or caveolar transcytosis (Figure 4).
Our results also reveal a striking difference between the cell
biological mechanisms of BBB disruption in mouse models of
multiple sclerosis and ischemic stroke. In t-MCAO, caveolar
density and albumin uptake in cortical endothelium are
enhanced as early as 6 hr after reperfusion of an occluded vessel
(Haley and Lawrence, 2017; Knowland et al., 2014). However,
high fractions of endothelial tight junction protrusions and gaps
associated with increased biocytin permeability are observed
only 24–48 hr after reperfusion (Haley and Lawrence, 2017;
Knowland et al., 2014). Therefore, the mechanisms that safe-
guard the transcellular endothelial barrier fail before those that
regulate the paracellular barrier in ischemic stroke (Haley and
Lawrence, 2017; Knowland et al., 2014). In contrast, paracellular
permeability is an early and persistent feature of EAE, whereas
transcellular permeability is only elevated during severe stages
of the disease (Figures 3 and 4; Figure S4C). This mechanistic di-
chotomy for barrier breakdown during t-MCAO versus EAE may
be due to either distinct inflammatory triggers or the timing when
leukocyte subsets infiltrate the CNS in these two disorders
(Lopes Pinheiro et al., 2016).
Our analysis reveals a role for caveolae in selective trafficking
of specific T cell subtypes across the BSCB. We find that mice
lacking caveolae (Razani et al., 2001) are partially protected
from EAE, demyelination, and infiltration of INF-g-producing
Th1 subtypes into the spinal cord (Figure 5). Our data are consis-
tent with a study showing that Cav1/ mice are protected from(F–I) Apical and basal confocal images and orthogonal views of Rorc(gt)GFP/+ Th
(green), CD45 (white), and DAPI (blue) on wild-type brain endothelial cells (apical
slice, I). Scale bar, 10 mm.
(J) Stacked bar graph indicating numbers of transcellular and paracellular transm
Significantly fewer Th1 cells transmigrate acrossCav1/ brain endothelial cells vi
with wild-type brain endothelial cells. Significantly fewer Th1 cells transmigrate acr
brain endothelial cells (p < 0.05).
(K) Model for lymphocyte trafficking across the BBB in EAE. Th1 cells preferentia
Th17 cells efficiently cross the BSCB through disrupted tight junctions (paracell
mation of membrane invaginations (protrusions) that fuse with EEA1+ endosome
See also Figure S5.EAE pathology and entry of T cells (Wu et al., 2016). However,
in contrast to that study, we find that the numbers of CD4+
and Th17+ lymphocytes that infiltrate the CNS are unchanged
between Cav1/ and wild-type EAE mice (Wu et al., 2016).
This discrepancy may be due to either interstrain genetic or mi-
crobiome differences between mice used in both studies. Our
study employed Cav1/ mice on a C57BL/6J background,
whereas Wu et al. (2016) used C57BL/6N. Because 0.8% of
genes differ between these substrains (Zurita et al., 2011), ge-
netic heterogeneity may contribute to the reported differences.
It is known that commensal segmented filamentous bacteria
(SFBs), present in BL/6N, drive Th17 differentiation (Ivanov
et al., 2009) and confer susceptibility to autoimmune arthritis in
BL/6J by enhancing IL-17A production (Wu et al., 2010), a cyto-
kine that disrupts tight junctions (Kebir et al., 2007). The gut mi-
crobiome regulates maturation of the BBB (Braniste et al., 2014)
and changes the phenotypic manifestation of cerebral
cavernous malformations, a CNS vascular disease, in the same
genetic background (Tang et al., 2017). These factors could
contribute to differences in the phenotype observed between
two studies in Cav1/ EAE mice.
Previous studies have indicated unique temporal profiles of Th1
and Th17 effector cell infiltration into theCNS. Th17 cells are high-
est in the EAE spinal cord at 7 days post-immunization and
decrease to baseline by day 10, whereas Th1 cells are low at
day 10 and escalate in the EAE spinal cord at day 14 (Murphy
et al., 2010). Consistently, adoptive transfer of Th17 cells that
are differentiated ex vivo induces more rapid clinical presentation
of disease compared with adoptive transfer of Th1 cells differen-
tiated ex vivo (Rothhammer et al., 2011). Our finding that Cav1 is
not required for early tight junction remodeling and early develop-
ment of clinical EAE is consistent with caveolin-independent tight
junction remodeling driving Th17 infiltration and disease initiation,
followed by caveolar transcytosis driving Th1 infiltration and dis-
ease propagation. Our tracer experiments support this idea. The
tight junction-permeant tracer biocytin-TMR crosses the BBB at
early or mild EAE, whereas the transcellular tracer albumin
crosses at severe stages of disease. Fibrinogen promotes de
novo caveolae formation in brain endothelial cells (Muradashvili
et al., 2014) andmay contribute to enhanced transcellular perme-
ability at severe EAE (Figure 4). Our findings suggest that efforts to
inhibit caveolar transcytosis hold therapeutic potential to counter
neuroinflammation in multiple sclerosis patients.
Why do Th1 cells preferentially cross the BSCB via caveolae
during EAE? Cell adhesion molecules such as intercellular adhe-
sion molecule 1 and 2 (ICAM-1/2) and vascular cell adhesion17 (EGFP+) in vitro transmigration assay immunostained for ZO-1 (red), GFP
slice, F; basal slice, G) or Cav1/ brain endothelial cells (apical slice, H; basal
igrating Th1 or Th17 cells across wild-type or Cav1/ brain endothelial cells.
a either transcellular routes (p < 0.05) or paracellular routes (p < 0.05) compared
ossCav1/ brain endothelial cells comparedwith Th17 cells crossingCav1/
lly deploy caveolae to cross the BSCB (transcellular permeability). In contrast,
ular permeability), as well as caveolae. Tight junction remodeling involves for-
s independently of caveolae.
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molecule 1 (VCAM-1) are enriched in caveolae and support
transcellular migration by engaging infiltrating cell podocytes
(Abadier et al., 2015; Carman and Martinelli, 2015; Millán et al.,
2006). Th17 cells rely primarily on an aLb2/ICAM-1 interaction
(Rothhammer et al., 2011; Stromnes et al., 2008), whereas Th1
cells employ an a4/VCAM-1 complex for migration (Glatigny
et al., 2011). Therefore, selective interactions between these
adhesionmolecules may direct Th1 cells more effectively toward
caveolae when crossing the endothelium during neuroinflamma-
tion. We have recently shown that partial protection conferred
by activation of Wnt/b-catenin signaling in the neurovascula-
ture during EAE is associated with suppression of Caveolin1,
VCAM-1, and T cell infiltration (Lengfeld et al., 2017). Our findings
therefore suggest that inhibiting both tight junction degradation
and caveolar transcytosis is a rationale for future therapies




All experimental procedures were approved by Institutional Animal Care and
Use Committee (IACUC) regulatory bodies at Columbia University Medical
Center and the University of California, Irvine. Generation of transgenic
eGFP-Claudin5+/ has been described (Knowland et al., 2014). Cav1/
mice (Razani et al., 2001) and Rorc(gt)GFP/+ mice (Ivanov et al., 2006) were ob-
tained from the Jackson Laboratory (Maine). All mice were backcrossed to the
C57BL/6J strain (Jackson Laboratory) for more than 8 generations.
EAE Induction
EAE was induced in 8- to 12-week-old female mice by subcutaneous immuni-
zation with a 100 mL emulsion of 100 mg of MOG35–55 peptide (MEVG
WYRSPFSRVVHLYRNGK) (Thermo Fisher Scientific) in PBSwith CFA contain-
ing 200 mg ofMycobacterium tuberculosis H37Ra (Difco). The day of MOG im-
munization was designated as day 0. Mice received intravenous injections of
400 ng ofB. pertussis toxin (List Biological Laboratories) 0 and 2 days post-im-
munization. Control animals received B. pertussis toxin and emulsion contain-
ing PBS/CFA without MOG. Mice were examined for clinical EAE signs using
the following scale, with 0.5-point gradations for intermediate presen-
tation: 0, no signs; 1, flaccid tail; 2, hindlimb paresis; 3, hindlimb paralysis;
4, hindlimb and forelimb paralysis; and 5, moribund (Lutz et al., 2012).
Laminectomy and In Vivo Two-Photon Imaging
Mice were anesthetized with 2.5% isoflurane in O2 and maintained throughout
surgery and imaging at 1.5% isoflurane in O2 supplemented with subcutane-
ous carprofen (5 mg/kg) and lactated Ringer’s solution. Body temperature
was maintained at 37.5C using a feedback-controlled homeothermic heating
pad. Lumbar level 1 vertebra was removed, leaving the dura mater intact.
A 3 mm borosilicate #0 coverslip was implanted on a bed of 1.5% agarose
(in artificial cerebrospinal fluid) over the laminectomy site. The spinal column
was stabilized using a custom-made titanium chamber affixed to adjacent
vertebra with Vetbond and dental acrylic (Figure 1A). Intravital imaging was
performed on a two-photon microscope (Sutter MOM) with a 920 nm excita-
tion light (Mai Tai eHP Deep See, Spectra-Physics). Green fluorescence emis-
sion (Chroma 565 dcxr) was gathered using a 403 infrared objective (Olympus,
0.8 NA). ScanImage software (Pologruto et al., 2003) was used to acquire 60–
150 mm optical stacks beneath the dura, sampled in 0.5 or 1 mm steps axially.
Acquisition of each stack lasted 2–3min. Repeated time-lapse acquisition was
performed at intervals of 45 min. Capillaries were identified by morphology
(i.e., less than 2 endothelial cells across, <10 mm). Arterioles and venules
were differentiated by direction of blood flow (arteriole > capillary > venule >
median vein) and endothelial cell morphology (arterioles with elongated shape
and venules with cobblestone shape) (Knowland et al., 2014). Image dimen-
sions were 204.8 3 204.8 mm (512 3 512 pixels).2114 Cell Reports 21, 2104–2117, November 21, 2017Tight Junction Remodeling Analysis
Images were analyzed with Fiji software (Schindelin et al., 2012) as described
(Knowland et al., 2014). Optical slices in which the image was shifted by more
than 0.5 mm in the x or y plane or 1 mm in the z plane because of motion
artifacts were excised. Tight junction segments were defined as a continuous
line between two endothelial cell borders without bifurcation. Tight junction
segments were manually traced onto individual optical sections. Tight
junction segments that were not visible at all time points were omitted from
analysis. Protrusions were defined as EGFP-positive bulbous structures that
extend >1 mm from the long axis of a tight junction segment (Figure 1C, yellow
arrow). Protrusions not present at both the beginning and the end of the imag-
ing session were considered dynamic (Figure 1, red arrows). Gaps were
defined as tight junction segment discontinuities > 0.4 mm (Figure 1D).
Tortuous strands were defined as tight junction segments with multiple curvi-
linear sections departing >1 mm from the long axis (Figure 1C). The number
of protrusions, dynamic protrusions, gaps, and tortuous segments was
measured for each optical z section.
BBB Permeability In Vivo
Thirty minutes after intravenous injection of 1% biocytin-TMR or albumin-
Alexa Fluor 594 (Thermo Fisher Scientific), C57BL/6J, transgenic eGFP-
Claudin5+/; Cav1/ or eGFP-Claudin5+/ Cav1/ mice were perfused with
PBS and 4% paraformaldehyde (PFA). Tissues were post-fixed for 2–6 hr
with 4% PFA, washed with PBS, cryoprotected in 30% sucrose overnight,
embedded in optimal cutting temperature (OCT), and sectioned and immuno-
stained for Glut1 (Calbiochem, 1:2,000) to visualize blood vessels, fibrinogen
(LifeSpan Biosciences, 1:4,000) to visualize leakage across the BBB, and
streptavidin-Alexa Fluor 594 (Thermo Fisher Scientific, 1:2,000) to visualize
biocytin-TMR tissue distribution. Sections were imaged with a Zeiss
LSM700 confocal microscope. Biocytin-TMR leakage was quantified as
described (Knowland et al., 2014), by measuring the mean fluorescence inten-
sity in spinal cord sections, and was presented as ratios to mean fluorescence
intensities in liver sections. Three to six sections at thoracic spinal cord levels
and three to six sections at lumbar spinal cord levels were quantified and aver-
aged for each mouse. No significant differences in biocytin-TMR intensity
within the liver were noted among groups. Fibrinogen-positive pixels were
measured and divided by the area of the spinal cord section. Albumin-Alexa
Fluor 594 uptake was measured as described (Knowland et al., 2014). Albu-
min-Alexa Fluor 594 single-channel images were uniformly thresholded, and
pixels above the threshold were counted both within endothelial cells
(endothelial-associated albumin) and outside of endothelial cells (paren-
chyma-associated albumin) (Figure 4).
T Cell Differentiation and Transmigration In Vitro
For Th1 cultures, splenocytes from C57BL/6 mice were collected 6 days after
MOG immunization and cultured in Th1-polarizing conditions in the presence
of antigen (20 mg/mL MOG plus 1 ng/mL IL-12, in RPMI supplemented with
fetal bovine serum (FBS), L-glutamine, beta-mercaptoethanol, and non-essen-
tial amino acids) (Murphy et al., 2010). After 4 days, 5 ng/mL of IL-2were added
(Murphy et al., 2010). After 7 days in culture, production of the Th1 cytokine
IFN-g increased 4,000% (Figure S5C) (data not shown). For Th17 cultures,
splenocytes from Rorc(gt)GFP/+ (Ivanov et al., 2006) were collected 6 days after
MOG immunization and cultured in Th17-polarizing conditions with antigen:
20 mg/mL MOG, 10 ng/mL IL-1b, 30 ng/mL IL-6, 3 ng/mL transforming growth
factor b (TGF-b), 10 mg/mL anti-IFN-g, and 10 mg/mL anti-IL-4. After 4 days,
20 ng/mL of IL-23 were added. After 3 additional days, cells were restimulated
with 0.5 mg/mL of plate-bound anti-CD3 and 0.5 mg/mL of soluble anti-CD28
(Cravens et al., 2016). Th17 cultures had 4,000-fold increased production
of IL-17 (Figure S5C). Th1 or Th17 cultures were applied to monolayers of pri-
mary mouse brain microvascular endothelial cells from wild-type or Cav1/
mice (Cell Biologics) grown on collagen IV-coated glass-bottom plates in the
presence of shear forces (10 dyn/cm2 orbital rotation) and activated overnight
with 1 ng/mL of tumor necrosis factor alpha (TNF-a) (Martinelli et al., 2014). In
some experiments, brain endothelial cells were pretreated for 2 hr with caveola
inhibitors genistein (Sigma, 400 mM), methyl-b-cyclodextrin (Sigma, 5 mM), or
vehicle (Opti-MEM, Gibco). T cells were allowed to adhere and transmigrate for
90 min at 37C, were washed 53 with warm Hank’s balanced salt solution
(HBSS), were fixed with 4% PFA, and were immunostained with anti-CD4 or
anti-CD45, anti-ZO-1, anti-GFP, and DAPI. An LSM700 confocal microscope
equipped with a 403 water-immersion objective was used to determine posi-
tions of cells as superficial (adherent) or transmigratory (Martinelli et al., 2014).
At least 50 cells per group were quantified across 6 wells per condition in three
independent experiments.
Immunofluorescence and Antibodies
Rabbit anti-Caveolin1 (Calbiochem, 1:4,000), rat anti-CD4 (BD Pharmingen
clone RM4-5, 1:100), rabbit anti-CD45 (Sigma, 1:250), rabbit anti-GFP
(1:1,000), mouse anti-ZO-1 (Invitrogen, 1:1,000), mouse anti-CC1 (Santa
Cruz, 1:200), rabbit anti-cleaved caspase-3 (Cell Signal, 1:250), rabbit anti-
fibrinogen (LifeSpan Biosciences, 1:4,000), rabbit anti-Glut1 (Calbiochem,
1:2,000), and rabbit anti-laminin (Sigma, 1:4,000). Cells immunoreactive for
CD4 inside the CNS parenchyma, and in meningeal and intraluminal spaces
(delineated by laminin staining), were counted for six to eight thoracic spinal
cord sections from each mouse. For unbiased measurement of myelinated
areas, Fiji software was used to measure fluoromyelin-positive pixels (Thermo
Fisher Scientific, 1:300) in uniformly thresholded images, which were ex-
pressed as a ratio of total white matter area.
Flow Cytometry
Spinal cords from wild-type and Cav1/ mice 15 days post-immunization
were homogenized between frosted glass slides. Mononuclear cells were iso-
lated at the interphase of a 30%–70% Percoll gradient (GE Healthcare). Drain-
ing lymph nodes and spleens were mechanically homogenized, and red blood
cells were lysed. Single-cell suspensions were restimulated for 5 hr in vitrowith
phorbol 12-myristate 13-acetate (PMA), ionomycin, brefeldin, and monensin
(eBioscience). After Fc receptor blockade, cells were stained with Live-Dead
Aqua (Invitrogen) plus antibodies against CD4-BV605 (BD Pharmingen),
CD8-phycoerythrin (PE)Cy5 (BioLegend), CD45-BV421 (BD Pharmingen),
and CD19-PECy7 (BD Pharmingen). Cells were then fixed, permeabilized,
and stained for IL-17a-PE (BD Pharmingen) and IFN-g-allophycocyanin
(APC) (BD Pharmingen). Unstained CNS mononuclear cells were used for sin-
gle-channel compensation, isotype controls, and fluorescence-minus-one
controls.
Statistical Analysis
We performed two-way t tests for pairwise comparisons and one-way ANOVA
followed by Newman-Keul’s multiple comparison tests for group effects. EAE
was assessed by two-way repeated-measure ANOVA followed by Sidak’s
multiple comparison test. EAE was analyzed in 34 wild-type and 32 Cav1/
mice. Mice with no clinical disease presentation were included in the analysis
(1 wild-type and 2 Cav1/), and animals that died during the experiment were
excluded from analysis (no wild-type and 2Cav1/). Statistical analyses were
performed with GraphPad Prism software, and statistical significance for all
figures is displayed as not significant (NS), p > 0.05, *p < 0.05, **p < 0.01,
and ***p < 0.001.
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